ConductScience.org, home

Paper511355

Trimethoprim/sulphonamide: concluding remarks.

Marget W. Infection, 1979. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Trimethoprim/sulphonamide: concluding remarks. Papers, record 511355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/511355

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Trimethoprim/sulphonamide: concluding remarks.
PubMed
Journal
Infection
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.09
iCite
Revised in PubMed
2019-08-27
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marget WW

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SulfonamidesMajor topic
TrimethoprimMajor topic
Urinary Tract InfectionsMajor topic
Aged
Animals
Child
Drug Administration Schedule
Drug Combinations
Humans
Sulfadiazine
Sulfamethoxazole

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1389810The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.Infection1979https://conductscience.org/library/papers/389810PubMed
2389811Efficacy of two trimethoprim-sulphonamide combinations in experimental pyelonephritis in the rat.Infection1979https://conductscience.org/library/papers/389811PubMed
3389808The effect of trimethoprim-sulphonamide, trimethoprim and sulphonamide on the occurrence of resistant enterobacteriaceae in human intestinal flora.Infection1979https://conductscience.org/library/papers/389808PubMed
4389814A clinical study of co-trimazine in comparison with co-trimoxazole and sulphalene in urinary tract infections.Infection1979https://conductscience.org/library/papers/389814PubMed
5389812Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim.Infection1979https://conductscience.org/library/papers/389812PubMed
6389816Clinical studies on co-trimazine in children.Infection1979https://conductscience.org/library/papers/389816PubMed
7511351Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.Infection1979https://conductscience.org/library/papers/511351PubMed
8389813Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections.Infection1979https://conductscience.org/library/papers/389813PubMed
9511354Comparison of long- and short-term treatment of recurrent urinary tract infection.Infection1979https://conductscience.org/library/papers/511354PubMed
10389809Synergistic activity of co-trimazine and co-trimoxazole in the urine.Infection1979https://conductscience.org/library/papers/389809PubMed
11511349Studies on the optimal dosage of co-trimazine in children.Infection1979https://conductscience.org/library/papers/511349PubMed
12511353General survey of trimethoprim combinations in the treatment of urinary tract infections.Infection1979https://conductscience.org/library/papers/511353PubMed
13389818Treatment of urinary tract infections with sulphonamide and/or trimethoprim. A preliminary report from a multipractice study.Infection1979https://conductscience.org/library/papers/389818PubMed
14389807Synergistic antibacterial activity in vitro of trimethoprim and sulphonamides and the importance of pharmacokinetic properties for optimal therapy.Infection1979https://conductscience.org/library/papers/389807PubMed
15511352Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function.Infection1979https://conductscience.org/library/papers/511352PubMed
16511347Co-trimazine distribution in the canine prostate.Infection1979https://conductscience.org/library/papers/511347PubMed
17511350Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 2: Comparative pharmacokinetics of five sulphonamides.Infection1979https://conductscience.org/library/papers/511350PubMed
18389817Clinical study of co-trimazine in urinary tract infections: a comparison with nitrofurantoin.Infection1979https://conductscience.org/library/papers/389817PubMed
19511348Renal lymph and interstitial fluid concentration of co-trimazine: an experimental study in dogs.Infection1979https://conductscience.org/library/papers/511348PubMed
20389815The use of co-trimazine and co-trimoxazole in elderly patients with urinary tract infections.Infection1979https://conductscience.org/library/papers/389815PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/511355

GET https://conductscience.org/api/papers/v1/511355/authors